
One major area of our research program is the development of synthetic strategies for compounds of interest in medicinal chemistry. We are especially interested in the synthesis of compounds with dense functionality containing one or more chiral centers. Our main approach in this endeavor is the utilization of chemical functionality from the vast structural reservoirs of carbohydrate materials found naturally. Using this approach we have developed synthetic routes to a variety of compound classes that are of interest in the design, development and manufacture of drugs used in therapeutic applications ranging from cholesterol lowering through cancer, infectious diseases, autoimmune disorders and diabetes. MORE
We also have an ongoing program in the area of biomaterial design. This is targeted at materials for uses such as drug delivery, implants and artificial tissue as well as for several environmental, sensor and diagnostic applications. We have developed several molecular platforms to facilitate the preparation of compounds with a wide spread of physical properties ranging from gels to resins to sheets to vesicles to lamellar systems aimed at a wide spectrum of end uses. MORE
The other major research interests of our laboratory are all focused on trying to understand what structural attributes regulate the behavior and properties of biomolecules in the context of living systems. We are especially interested in large ensemble systems, especially biomembranes. One major goal is to determine how biomembranes control or influence the behavior of macromolecules such as proteins and nucleic acids. The studies we are engaged in involve a large spectrum of biochemical, chemical, and physical methods. These include organic synthesis and a large variety of spectroscopic and computational tools, especially NMR and IR spectroscopy and molecular structure calculation, as well as the analysis and simulation of molecular dynamics. MORE
Gao L, Hollingsworth RI. Design and evaluation of dihydroxytetrahydro-1H-pyrrolo[2,1-c]- [1,4]benzothiazines as conformationally restricted transition-state inhibitors of beta-ribosidases. J Org Chem. 2005 Oct 28;70(22):9013-6.
Huang L, Hollingsworth RI, Castellani R, Zipser B.
Accumulation of high-molecular-weight amylose in Alzheimer's disease brains.
Glycobiology. 2004 May;14(5):409-16. Epub 2004 Jan 12.
Pistia-Brueggeman G, Hollingsworth
RI. "The use of the o-nitrophenyl group as a protecting/activating
group for 2-acetamido-2-deoxyglucose". Carbohydr Res. 2003; 338(5):455-8.
Song X, Hollingsworth RI. "Remote
site bromination via a cascade rearrangement involving two bridging
dioxonium species during oxidative cleavage of a benzylidene acetal".
Carbohydr Res. 2003; 338(4):369-73.
Burdette DS, Jung SH, Shen
GJ, Hollingsworth RI, Zeikus JG. "Physiological function of alcohol
dehydrogenases and long-chain (C(30)) fatty acids in alcohol tolerance
of Thermoanaerobacter ethanolicus". Appl Environ Microbiol. 2002;
(4):1914-8. MORE